Nikos Oikonomou
Nikos Oikonomou publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Sphingolipid Metabolism and Signaling, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Neonatal Respiratory Health Research.
- World rank
- #757,592 of 7,710,434 ranked researchers
- Rank in Greece
- #2,858 of 33,280
- Works
- 48
- Citations
- 1.5k
- Citations per work
- 32.2
What does Nikos Oikonomou research?
Nikos Oikonomou's work is mostly in Medicine (35%), Biochemistry, Genetics and Molecular Biology (32%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1734.7%
- Medicine1734.7%
- Everything else1633.3%
- Life Sciences1532.0%
- 1Molecular Biology24% of their works
- 2Pulmonary and Respiratory Medicine21% of their works
- 3Surgery11% of their works
- 4Cell Biology5% of their works
- 5Cardiology and Cardiovascular Medicine3% of their works
- 6Cancer Research3% of their works
Research topics
- Sphingolipid Metabolism and Signaling
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Neonatal Respiratory Health Research
- Endoplasmic Reticulum Stress and Disease
- Kruppel-like factors research
- Epigenetics and DNA Methylation
- Systemic Sclerosis and Related Diseases
- Lung Cancer Treatments and Mutations
Which keywords describe Nikos Oikonomou's research?
The keywords of their largest research topics: Apoptosis, Cancer, Fibrosis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Sphingolipids, Sphingosine-1-Phosphate and Bronchopulmonary Dysplasia.
- Systemic Sclerosis
- EGFR Mutations
- Autoantibodies
- Stress
- Endoplasmic Reticulum
- Bronchopulmonary Dysplasia
- Sphingolipids
- Idiopathic Pulmonary Fibrosis
- Cancer
- Apoptosis
- Fibrosis
- Interstitial Lung Disease
- Sphingosine-1-Phosphate
- Preterm Infants
- Krüppel-like Factors
- Transcriptional Regulation
- DNA Methylation
- Histone Modification
- Targeted Therapy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Apoptosis82 topics
- Cancer82 topics
- Fibrosis72 topics
- Idiopathic Pulmonary Fibrosis51 topic
- Interstitial Lung Disease51 topic
- Sphingolipids51 topic
- Sphingosine-1-Phosphate51 topic
- Bronchopulmonary Dysplasia41 topic
- Preterm Infants41 topic
- Endoplasmic Reticulum31 topic
- Krüppel-like Factors31 topic
- Stress31 topic
- Transcriptional Regulation31 topic
- Autoantibodies21 topic
- DNA Methylation21 topic
- EGFR Mutations21 topic
- Histone Modification21 topic
- Systemic Sclerosis21 topic
- Targeted Therapy21 topic
Where does Nikos Oikonomou work?
Nikos Oikonomou's main affiliation in the publication record is Alexander Fleming Biomedical Sciences Research Center, Greece.
How many publications and citations does Nikos Oikonomou have?
OpenAlex counts 48 works and 1,547 citations for Nikos Oikonomou, an h-index of 14, ranking #757,592 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nikos Oikonomou. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.